I used to hold a similar attitude towards charting penny stocks until someone dragged me into a group of investors to do their TA. Since then I have changed my mind on charting Speck stocks completely, because it is not only possible, but also very profitable. Profitable, simply because done probably the margins are bigger then in the blue chip sectors and possible because the same rules apply.
BTW, there really plenty of profitable chartists who trade stocks without knowing the FA facts or even what the companies are into. Been doing this myself as well from time to time. What does one do when one sees a chart that has everything going for it? Do 2 or more weeks research to find out everything there is to know about it or jump straight in and do the research later or never because the run only took 8 or 10 days? Do I really care what the company does, who the directors are and what’s their experience and expertise is? Who needs FA in such a case? Some say who needs FA at all when the chart incorporates all the knowns and even some of the (officially) unknowns!
New TA/Charting, page-868
-
- There are more pages in this discussion • 14,449 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LTR (ASX) to my watchlist
|
|||||
Last
97.0¢ |
Change
-0.030(3.00%) |
Mkt cap ! $2.352B |
Open | High | Low | Value | Volume |
$1.03 | $1.03 | 96.5¢ | $13.68M | 13.82M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 76446 | 96.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
97.5¢ | 50000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 54268 | 0.965 |
16 | 448006 | 0.960 |
10 | 273881 | 0.955 |
34 | 357765 | 0.950 |
7 | 148508 | 0.945 |
Price($) | Vol. | No. |
---|---|---|
0.975 | 50000 | 1 |
0.980 | 30256 | 2 |
0.985 | 5873 | 2 |
0.990 | 28958 | 4 |
0.995 | 8676 | 3 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
LTR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online